Title

Stephen W. Schwarzmann Distinguished Professor of Medicine

Specialty/Subspecialty

Infectious

Clinical Interest(s)

NIH, CTSA Strategic Goal 4, Enhancing the Health of our Communities and the Nation

Research Interest(s)

• Genetic and molecular mechanisms of bacterial pathogenesis
• Pathogenesis, pathophysiology and epidemiology of Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae and the other agents of bacterial meningitis
• Bacterial vaccines
• Innate immunity

Current / Former SSCI Roles

Publications

http://www.ncbi.nlm.nih.gov/sites/entrez

About David S. Stephens, MD

David S. Stephens, MD, is Vice President for Research in the Robert W. Woodruff Health Sciences Center (WHSC), a position in which he oversees the WHSC research enterprise and leads planning activities that enhance research programs and collaborations throughout the WHSC and Emory University. He is also the Chair of the Department of Medicine and the Chief of Medicine, Emory Healthcare. He is the Stephen W. Schwarzmann Distinguished Professor of Medicine.

After receiving his MD degree from Wake Forest University School of Medicine, Dr. Stephens conducted research at Walter Reed Army Medical Center and the National Institutes of Health (NIH). He completed his clinical training in internal medicine and infectious diseases and a research fellowship in microbial pathogenesis at Vanderbilt University School of Medicine.

Dr. Stephens joined Emory's Department of Medicine faculty in 1982 and was named director of the Division of Infectious Diseases in 1992. He served in that role until 2013 and led the development of very successful programs in infectious diseases and microbial pathogenesis. He has been a major contributor to the creation and development of the NIH-funded Emory Vaccine Center, the

Emory Center for AIDS Research and the Serious Communicable Diseases Unit (SCDU) at Emory.

Dr. Stephens has led research initiatives in the School of Medicine (Executive Associate Dean 2005-2008) and as the Vice President of Research (2008-present). Researchers at Emory University received $521.8 million from external funding agencies in fiscal year 2014. This marks the fifth consecutive year that extramural research funding has exceeded $500 million.

Dr. Stephens is also professor of microbiology and immunology in the School of Medicine and professor of epidemiology at Emory's Rollins School of Public Health. He is chair of the Research Advisory Council in the WHSC and a member of the Executive Committee on the WHSC Leadership Team.

His laboratory is an international leader in efforts to define the molecular basis for the virulence of and vaccines to prevent bacterial meningitis, especially disease caused by Neisseria meningitidis and Streptoccous pneumoniae. He has contributed to more than 300 publications in infectious diseases, molecular pathogenesis, epidemiology, vaccinology and immunology.